A preclinical murine model of hepatic metastases

Journal of Visualized Experiments

Volumn , Issue 91, 2014, Pages

  Soares, Kevin C ^a   Foley, Kelly ^b   Olino, Kelly ^a   Leubner, Ashley ^b   Mayo, Skye C ^a   Jain, Ajay ^a   Schulick, Richard D ^b   Jaffee, Elizabeth ^c   Yoshimura, Kiyoshi ^a,b   Edil, Barish ^a,b   Zheng, Lei ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Hemispleen; Hepatic Metastases; Immunotherapy; Issue 91; Liver; Medicine; Metastatic; Murine; Pancreatic Cancer; Pancreatic Neoplasms; Preclinical Model

Indexed keywords

ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; DISEASE MODEL; EXPERIMENTAL LIVER NEOPLASM; FEMALE; MOUSE; PANCREAS TUMOR; PATHOLOGY; SECONDARY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS;

EID: 84908330270     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/51677     Document Type: Article

References (13)

1. American Cancer Society. Cancer Facts & Figures 2013. Atlanta. American Cancer Society (2013).
2. Clark, C. E., Beatty, G. L., & Vonderheide, R. H. Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer. Cancer letters. 279, 1-7, doi:10.1016/j.canlet.2008.09.037 (2009).
3. Rhim, A. D. et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349-361, doi:10.1016/j.cell.2011.11.025 (2012).
4. Frese, K. K., & Tuveson, D. A. Maximizing mouse cancer models. Nature reviews. Cancer. 7, 645-658, doi:10.1038/nrc2192 (2007).
5. Corbett, T. H. et al. Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. Cancer research 44, 717-726 (1984).
6. Leao, I. C., Ganesan, P., Armstrong, T. D., & Jaffee, E. M. Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinoma. Clinical and translational science. 1, 228-239, doi:10.1111/j.1752-8062.2008.00070.x (2008).
7. Jain, A. et al. Synergistic effect of a granulocyte-macrophage colony-stimulating factor-transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastases. Annals of surgical oncology 10, 810-820 (2003).
8. Yoshimura, K. et al. Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes. Cancer research 66, 1096-1104, doi:10.1158/0008-5472.CAN-05-2307 (2006).
9. Yoshimura, K. et al. Live attenuated Listeria monocytogenes effectively treats hepatic colorectal cancer metastases and is strongly enhanced by depletion of regulatory T cells. Cancer research 67, 10058-10066, doi:10.1158/0008-5472.CAN-07-0573 (2007).
10. Olino, K. et al. Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases. Annals of surgical oncology 19 Suppl 3, S597-607, doi:10.1245/s10434-011-2037-0 (2012).
11. Hingorani, S. R. et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer cell 7, 469-483, doi:10.1016/j.ccr.2005.04.023 (2005).
12. Marion, A., Aoudi, W., Basarab, A., Delachartre, P., & Vray, D. Blood flow evaluation in high-frequency, 40 MHz imaging: a comparative study of four vector velocity estimation methods. Ultrasonics. 50, 683-690, doi:10.1016/j.ultras.2010.01.008 (2010).
13. Zheng, L. et al. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PloS one 6, e19390, doi:10.1371/journal.pone.0019390 (2011)